Open Access
Research (Published online: 23-02-2019)
19. Antiretroviral activity of Pterois volitans (red lionfish) venom in the early development of human immunodeficiency virus/acquired immunodeficiency syndrome antiretroviral alternative source
Andy Noorsaman Sommeng, R. Muhammad Yusuf Arya, Mikael Januardi Ginting, Diah Kartika Pratami, Heri Hermansyah, Muhamad Sahlan and Anondho Wijanarko
Veterinary World, 12(2): 309-315

Andy Noorsaman Sommeng: Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia, Indonesia.
R. Muhammad Yusuf Arya: Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia, Indonesia.
Mikael Januardi Ginting: Marine Science Postgraduate Program, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Indonesia.
Diah Kartika Pratami: Laboratory of Pharmacognosy and Phytochemistry, Faculty of Pharmacy, Pancasila University, Indonesia.
Heri Hermansyah: Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia, Indonesia.
Muhamad Sahlan: Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia, Indonesia; Research Center for Biomedical Engineering, Faculty of Engineering, Universitas Indonesia, Indonesia.
Anondho Wijanarko: Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia, Indonesia.

doi: 10.14202/vetworld.2019.309-315

Share this article on [Facebook] [LinkedIn]

Article history: Received: 16-09-2018, Accepted: 02-01-2019, Published online: 23-02-2019

Corresponding author: Muhamad Sahlan

E-mail: sahlan@che.ui.ac.id

Citation: Sommeng AN, Arya RMY, Ginting MJ, Pratami DK, Hermansyah H, Sahlan M, Wijanarko A (2019) Antiretroviral activity of Pterois volitans (Red Lionfish) venom in the early development of human immunodeficiency virus/acquired immunodeficiency syndrome antiretroviral alternative source, Veterinary World, 12(2): 309-315.
Abstract

Aim: This study aimed to investigate the antiviral activity of Pterois volitans phospholipase A2 (PV-PLA2) from Indonesia to human immunodeficiency virus (HIV).

Materials and Methods: Fresh venomous fin parts of wild PV specimens were collected from Java Sea waters. Then, it washed using phosphate buffer pH 7.0 and immersed in phosphate buffer pH 7.0 0.01 m containing CaCl2 0.001 m for 24 h. The immersed fin then allowed for extraction process by sonicating for 2×8 min with 80% pulse and 20 kHz output with temperature controlling to avoid denaturation. The crude venom (CV) extracted from the fin is allowed for purification by 80% ethanol (ET) precipitation and ammonium sulfate fractionation method. The purified PV-PLA2 then analyzed using Lowry's method, Marinette's method, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and 3-(4, 5-dimethyl thiazol-2yl)-2, 5-diphenyl tetrazolium bromide assay. After determining the purest and safest sample of six samples analyzed, the chosen sample then tested into simian retrovirus-2 (SRV2)-A549 culture (48×104 cells/mL at 1-4 ppm), and compared to the CV sample (1-4 ppm) and lamivudine (100 ppm). The culture then is analyzed using a quantitative real time-polymerase chain reaction to find out the copy number of SRV-2 virus in each culture.

Results: The protein's activity, concentration, and purity analysis revealed that the PV-PLA2 purified using ammonium sulfate fractionation has the highest activity (1.81 times higher than the CV at 80% fractionation) and has higher purity than the sample from ET fractionation. The testing of the sample purified using ammonium sulfate fractionation at 80% saturation level shown that it has a 97.78% inhibition level toward SRV2-A549 culture at 4 ppm. However, in comparison to lamivudine which has 99.55% inhibition level at 100 ppm, it needs much lower concentration to achieve the same result.

Conclusion: The significant inhibition of SRV2-A549 culture shown that the PV-PLA2 extracted from PV venom has the potential to become anti-HIV substances. It would be worthwhile to further evaluate the antiretroviral activity of PV-PLA2 in the in vivo studies.

Keywords: antiretrovirus, lamivudine, phospholipase A2, Pterois volitans, simian retrovirus serotype 2.

References

1. Albins, M.A. and Hixon, M.A. (2008) Invasive Indo-Pacific lionfish Pterois volitans reduce recruitment of Atlantic coral-reef fishes. Mar. Ecol. Prog. Ser., 367:233-238. [Crossref]

2. Albins, M.A. (2015) Invasive Pacific lionfish Pterois volitans reduce abundance and species richness of native Bahamian coral-reef fishes. Mar. Ecol. Prog. Ser., 522:231-243. [Crossref]

3. Cote, I.M., Green, S.J. and Hixon, M.A. (2013) Predatory fish invaders: Insights from Indo-Pacific lionfish in the Western Atlantic and Caribbean. Biol. Conserv., 164: 50-61. [Crossref]

4. Cote, I.M. and Smith, N.S. (2018) The lionfish Pterois Sp. Invasion: Has the worst case scenario come to pass? J. Fish Biol., 92(3): 660-689. [Crossref] [PubMed]

5. Hixon, M.A., Green, S.J., Albins, M.A., Akins, J.L. and Morris J.A Jr. (2016) Lionfish: A major marine invasion. Mar. Ecol. Prog. Ser., 558: 161-165. [Crossref]

6. Chappell, B.F. and Smith, K.G. (2016) Patterns of predation of native reef fish by invasive Indo-Pacific lionfish in the Western Atlantic: Evidence of selectivity by a generalist predator. Glob. Ecol. Conserv., 8: 18-23. [Crossref]

7. Vetrano, S.J., Lebowitz, J.B. and Marcus, S. (2002) Lionfish envenomation. J. Emerg. Med., 23(4): 379-382. [Crossref]

8. Fenard, D., Lambeau, G., Maurin, T., Lefebvre, J.C. and Doglio, A. (2001) A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor. Mol. Pharmacol., 60(2): 341-347. [Crossref]

9. Kim, J.O., Chakrabarti, B.K., Guha-Niyogi, A., Louder, M.K., Mascola, J.R., Ganesh, L. and Nabel, G.J. (2007) Lysis of human immunodeficiency virus Type 1 by a specific secreted human phospholipase A2. J. Virol., 81(3): 1444-1450. [Crossref] [PubMed] [PMC]

10. Wijanarko, A., Lischer, K., Hermansyah, H., Pratami, D.K. and Sahlan, M. (2018) Antiviral activity of Acanthaster planci phospholipase A2 against human immunodeficiency virus. Vet. World, 11(6): 824-829. [Crossref] [PubMed] [PMC]

11. Ibrahim, F., Widhyastuti, N., Savitri, I.K.E., Sahlan, M. and Wijanarko, A. (2013) Antibacterial investigated of phospholipase A2 from the spines venom of the crown of thorns starfish Acanthaster planci. Int. J. Pharm. Bio Sci., 4(2): 1-5.

12. Shiomi, K.A., Kazama, A., Shimakura, K. and Nagashima, Y. (1998) Purification and properties of phospholipases A2 from the crown-of-thorns starfish (Acanthaster planci) venom. Toxicon, 36(4): 589-599. [Crossref]

13. Wei, M., Xing, H., Feng, Y., Hsi, J.H., Liu, P. and Shao, Y. (2015) Estimating HIV-1 transmission routes for patients with unknown risk histories by viral sequence phylogenetic analyses. JAIDS J. Acquir. Immune Defic. Syndr., 70(2): 195-203. [Crossref] [PubMed]

14. Cohen, M.S., Chen, Y.Q., McCauley, M., Gamble, T., Hosseinipour, M.C., Kumarasamy, N., Hakim, J.G., Kumwenda, J., Grinsztejn, B., Pilotto, J.H.S., Godbole, S.V., Chariyalertsak, S., Santos, B.R., Mayer, K.H., Hoffman, I.F., Eshleman, S.H., Piwowar-Manning, E., Cottle, L., Zhang, X.C., Makhema, J., Mills, L.A., Panchia, R., Faesen, S., Eron, J., Gallant, J., Havlir, D., Swindells, S., Elharrar, V., Burns, D., Taha, T.E., Nielsen-Saines, K., Celentano, D.D., Essex, M., Hudelson, S.E., Redd, A.D. and Fleming, T.R. (2016) Antiretroviral therapy for the prevention of HIV-1 transmission. N. Engl. J. Med., 375(9): 830-839. [Crossref] [PubMed] [PMC]

15. Lindayani, L., Chen, Y.C., Wang, J.D. and Ko, N.Y. (2018) Complex problems, care demands, and quality of life among people living with HIV in the antiretroviral era in Indonesia. J. Assoc. Nurses AIDS Care, 29(2): 300-309. [Crossref] [PubMed]

16. Siregar, A.Y.M., Tromp, N., Komarudin, D., Wisaksana, R., van Crevel, R., van der Ven, A. and Baltussen, R. (2015) Costs of HIV/AIDS treatment in Indonesia by time of treatment and stage of disease. BMC Health Serv. Res., 15(1): 440. [Crossref]

17. Savitri, I.K.E., Ibrahim, F., Sahlan, M. and Wijanarko, A. (2011) Rapid and efficient purification method of phospholipase A2 from Acanthaster planci. Int. J. Pharm. Bio Sci., 2(2): 401-406.

18. Marinetti, G.V. (1965) The action of phospholipase A on lipoproteins. Biochim. Biophys. Acta Lipids Lipid Metab., 98(3): 554-565. [Crossref]

19. Choromanski, J.M. (1985) Chemical Stabilization and Pharmacological Characterization of the Venom of the Lionfish, Pterois volitans, Master Thesis of Oregon State University, United States.

20. Memar, B., Jamili, S., Shahbazzadeh, D. and Bagheri, K.P. (2016) The first report on coagulation and phospholipase A2 activities of Persian Gulf lionfish, Pterois russelli, an Iranian venomous fish. Toxicon, 113: 25-31. [Crossref] [PubMed]

21. Savitri, I.K.E., Sahlan, M., Ibrahim, F. and Wijanarko, A. (2012) Isolation and characterization of phospholipase A2 from the spines venom of the crown-of-thorns starfish isolated from Papua island. Int. J. Pharm. Bio Sci., 3(4): 603-608.

22. Suliman, Y.A.O., Ali, D., Alarifi, S., Harrath, A.H., Mansour, L. and Alwasel, S.H. (2015) Evaluation of cytotoxic, oxidative stress, proinflammatory and genotoxic effect of silver nanoparticles in human lung epithelial cells. Environ. Toxicol., 30(2): 149-160. [Crossref] [PubMed]

23. Wang, R., Sun, D.Z., Song, C.Q., Xu, Y.M., Liu, W., Liu, Z. and Dong, X.S. (2018) Eukaryotic translation initiation factor 2 subunit a (eIF2a) inhibitor salubrinal attenuates paraquat-induced human lung epithelial-like A549 cell apoptosis by regulating the PERK-eIF2a signaling pathway. Toxicol. In Vitro, 46: 58-65. [Crossref] [PubMed]

24. Khusro, A., Aarti, C., Barbabosa-Pliego, A., Rivas-Caceres, R.R. and Cipriano-Salazar, M. (2018) Venom as therapeutic weapon to combat dreadful diseases of 21st century: A systematic review on cancer, TB, and HIV/AIDS. Microb. Pathog., 125: 96-107. [Crossref]

25. Zhao, Y. and Chen, P. (2014) Natural products with health benefits from marine biological resources. Curr. Org. Chem., 18(7): 777-792. [Crossref]

26. Villarrubia, V.G., Costa, L.A. and Diez, R.A. (2004) Secreted phospholipases A2 (sPLA2): Friends or foes? Are they actors in antibacterial and anti-HIV resistance? Med. Clin. (Barc), 123(19): 749-757.

27. Uzair, B., Bushra, R., Khan, B.A., Zareen, S. and Fasim, F. (2018) Potential use of venom proteins in treatment of HIV. Protein Pept. Lett., 25(7): 619-625. [Crossref] [PubMed]